Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia
Clinical trial NCT04856111 · UNKNOWN
Trial details
- NCT number
- NCT04856111
- Sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2022-11-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.